N-(butenyl substituted) azaheterocyclic carboxylic acids

Details N-(butenyl substituted) azaheterocyclic carboxylic acids N-(butenyl substituted) azaheterocyclic carboxylic acids

1988-10-07

1991-04-23

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546208, 546212, 546214, 546193, 514422, 548524, 548527, C07D40114

Patent

active

050100904

ABSTRACT:
1-Aminobut-3-en derivatives having optionally substituted furanyl, thienyl, pyridyl and/or pyrrolyl in the 4-position and 3-carboxypiperidin-1-yl, 3-carboxytetrahydropyrid-1-yl or 3 carboxymethylpyrrolidin-1-yl in the 1-position potentiate GABA-ergic neurotransmission.

REFERENCES:
patent: 4383999 (1983-05-01), Bondinell
patent: 4514414 (1985-04-01), Bondinell
patent: 4931450 (1990-06-01), Sonnewald
Yunger et al., Jour. Pharmac. Exptc. Therap., vol. 228 (No. 1), pp. 109-115 (1984).
Burger, "Medicinal Chemistry", 2nd Ed. Interscience, N.Y. 1960, p. 43.

Affiliated with

Also associated with

Rating

N-(butenyl substituted) azaheterocyclic carboxylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-(butenyl substituted) azaheterocyclic carboxylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(butenyl substituted) azaheterocyclic carboxylic acids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1621590